- Tezepelumab - a novelty in the treatment of severe asthma2023 | Faculty of Medicine in Pilsen
- Immunopathogenesis of type 1 diabetes and the possibility of influencing autoimmune insulitis – what’s new?2023 | Second Faculty of Medicine
- Toward clinically applicable biomarkers for asthma: An EAACI position paper2019 | First Faculty of Medicine
- Periostin - a novel promising biomarker of bronchial asthma and idiopathic pulmonary fibrosis2013 | Faculty of Medicine in Hradec Králové
- Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma2020 | First Faculty of Medicine
- Food allergy in 2019 Fodd allergy in 20192019 | Faculty of Medicine in Pilsen
- Functional lung examination in diagnostics of asthma and its phenotypes2018 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Biological treatment of bronchial asthma - first clinical experience with mepolizumab2017 | Faculty of Medicine in Hradec Králové
- Nasal polyposis2021 | Third Faculty of Medicine
- Alarmins - novel targets for biological therapy2023 | Faculty of Medicine in Hradec Králové
- Mepolizumab in treating severe asthma2016 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Allergen bronchoprovocation test: an important research tool supporting precision medicine2021 | First Faculty of Medicine
- Asthma: a modifiable disease on a crossroad2020 | First Faculty of Medicine
- Integrating innovations in asthma research into clinical practice2023 | First Faculty of Medicine
- Asthma in the era of COVID-192023 | First Faculty of Medicine
- Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient2023 | First Faculty of Medicine
- Blood eosinophils: In quest of a Holy Grail for personalized asthma treatment with biologicals2020 | First Faculty of Medicine
- Personalized Medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model2021 | Faculty of Medicine in Pilsen
- EUFOREA consensus on biologics for CRSwNP with or without asthma2019 | First Faculty of Medicine
- New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis2023 | First Faculty of Medicine, Second Faculty of Medicine
- Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhihosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement2017 | Faculty of Medicine in Pilsen
- COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations2022 | Second Faculty of Medicine
- Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps2021 | First Faculty of Medicine